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Noncovalent protein–ligand complexes are readily detected by electrospray ionization mass
spectrometry (ESI-MS). Ligand binding stoichiometry can be determined easily by the ESI-MS
method. The ability to detect noncovalent protein–ligand complexes depends, however, on the
stability of the complexes in the gas-phase environment. Solution binding affinities may or may
not be accurate predictors of their stability in vacuo. Complexes composed of cytidine
nucleotides bound to ribonuclease A (RNase A) and ribonuclease S (RNase S) were detected
by ESI-MS and were further analyzed by MS/MS. RNase A and RNase S share similar
structures and biological activity. Subtilisin-cleavage of RNase A yields an S-peptide and an
S-protein; the S-peptide and S-protein interact through hydrophobic interactions with a
solution binding constant in the nanomolar range to generate an active RNase S. Cytidine
nucleotides bind to the ribonucleases through electrostatic interactions with a solution binding
constant in the micromolar range. Collisionally activated dissociation (CAD) of the 1:1 RNase
A-CDP and CTP complexes yields cleavage of the covalent phosphate bonds of the nucleotide
ligands, releasing CMP from the complex. CAD of the RNase S-CDP and CTP complexes
dissociates the S-peptide from the remaining S-protein/nucleotide complex; further dissocia-
tion of the S-protein/nucleotide complex fragments a covalent phosphate bond of the
nucleotide with subsequent release of CMP. Despite a solution binding constant favoring the
S-protein/S-peptide complex, CDP/CTP remains electrostatically bound to the S-protein in
the gas-phase dissociation experiment. This study highlights the intrinsic stability of electro-
static interactions in the gas phase and the significant differences in solution and gas-phase
stabilities of noncovalent complexes that can result. (J Am Soc Mass Spectrom 2008, 19,
1199–1208) © 2008 American Society for Mass SpectrometryThe biological function of many macromoleculesoften requires the binding of small molecules andions. For proteins in general, such binding in-
volves the formation of noncovalent bonds between the
small molecule or ion (i.e., ligand) and protein at a
specific region or surface of the protein. Most biological
macromolecules possess binding sites of varying de-
grees of strength and specificity for a variety of ligands.
The binding of ligands could be a complex process, as
the binding event may induce a conformational change
in the structure of the protein. Mass spectrometry (MS),
especially with electrospray ionization (ESI), has been
applied for the analysis of protein complexes involving
noncovalent interactions with a variety of partners (e.g.,
other peptides and proteins, small molecule ligands,
metal ions, oligonucleotides, etc) since the early 1990s
[1–4], and especially during the past few years [5–10].
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doi:10.1016/j.jasms.2008.05.012Very large protein assemblies, such as the 700 kDa 20S
proteasome [11–13], the 2 MDa ribosome, and other
large megadalton complexes [8, 10, 14, 15] are suffi-
ciently stable for ESI mass spectrometry detection. The
molecular weight range for the detection of protein
complexes can be extended by coupling ESI with ion
mobility analysis, for example, for the detection of
MDa-sized viral particles and other large assemblies
greater than 10 MDa [16–18].
As ESI-MS is being applied for the characterization
of noncovalent protein complexes, a better understand-
ing of the relative stability of protein–ligand complexes
both in solution and in the gas phase becomes very
important for the interpretation of such measurements.
In general, the sites of protein ligand binding can be
identified or inferred by a number of biophysical meth-
ods, such as using hydrogen-deuterium exchange cou-
pled with MS detection, high resolution X-ray crystal-
lography and NMR, chemical and photo cross-linking,
and other techniques. The direct detection of protein–
ligand noncovalent complexes using ESI mass spec-
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1200 YIN ET AL. J Am Soc Mass Spectrom 2008, 19, 1199–1208trometry can be challenging, depending on the types of
compounds tested and the types of physical interac-
tions necessary to maintain a stable complex in both
solution and in the gas phase.
In principle, one can envision that an ESI-MS-based
assay could be developed to assess the binding capabil-
ities of small molecule compounds (of less than 1000
Da) to a targeted protein. In fact, with moderate-to-high
resolving mass analyzers, such as a time-of-flight (TOF),
Fourier-transform ion cyclotron resonance (FT-ICR)
system, or an Orbitrap, throughput and capacity could
be greatly increased by multiplexing either the com-
pounds in the form of compound mixtures or libraries
and/or the protein targets for known protein and
compound entities. Pharmaceutical and biotechnology
organizations could apply such a moderate throughput
assay for more targeted compound screens to support
structure–activity relationship (SAR) studies. The tech-
nology for such an instrument platform is readily
available with automated liquid handling robots and
nanoESI-chip devices for analyte introduction and ion-
ization. One should be able to acquire a mass spectrum
for the protein–ligand complex every 30 s or less;
compound concentrations can be varied to construct a
titration curve for solution-phase equilibrium binding
constant determinations. Previous literature suggests
that the concept is feasible [19]. However, it has not
been put into large-scale practice for a variety of rea-
sons. In our opinion, one of the primary reasons is that
the avidity of the ligand in the gas phase may not
mirror its behavior in solution.
Removal of water from a protein (i.e., dehydration)
has unknown consequences on its structural integrity
and its interactions with ligands and other macromole-
cules [20]. The fact that many noncovalently-bound
protein complexes can be observed intact suggests that
the removal of water itself may not cause dissociation of
the protein complex in vacuo. Potentially, there are
competing factors that can stabilize and destabilize
protein interactions in the gaseous state. The electro-
static potential between two point charges in vacuum is
given by Coulomb’s law. In homogeneous environ-
ments, the electrostatic interaction is inversely propor-
tional to the dielectric constant of the medium; the
dielectric constant of water is 78.5 (25 °C), and values
for the dielectric constant for the interior of a protein
range from 1 to 20. Removing water may serve to
increase the electrostatic interaction between two oppo-
sitely charged molecules, but the degree of this increase
is unclear [21]. The stability of some macromolecules
and protein complexes may derive in large part from
hydrophobic bonding. It is unlikely that hydrophobic
interactions persist in the vacuum state. Indeed, it has
been suggested by several studies that protein–protein
and protein–ligand complexes driven by hydrophobic
interactions are sufficiently unstable in the gas phase to
preclude their detection by ESI-MS [7, 22]. However,
there are limited reports of successful detection of such
complexes [3, 23], including lipid–peptide complexesby Cole’s group [24]. Thus, the stability of the gas-phase
protein–ligand complex may not always mirror pre-
cisely its stability in the solvated state [7, 25].
In this report, we highlight the differences between
electrostatic and hydrophobic interactions by our
ESI-MS study of ribonuclease A (RNase A) and ribonu-
clease S (RNase S). RNase A has been a primary object
of landmark work on the folding, stability, and chem-
istry of proteins, and in enzymology [26]. RNase A
catalyzes the cleavage of the P–O 5= bond of single-
stranded ribonucleic acids on the 3=-side of cytidine and
uridine residues. This cleavage reaction requires the
2=-hydroxyl group of RNA; RNase A does not hydro-
lyze DNA. Protein–nucleotide complexes have been
detected using ESI-MS [14, 27–30]. More specifically,
the complexation of mono- and oligonucleotide ligands
with ribonuclease A has been measured using ESI-MS
by many laboratories [14, 19, 31–33].
RNase S is formed by the cleavage of a single bond in
native RNase A by the protease, subtilisin [34]. The
product of subtilisin cleavage generally generates two
tightly associated fragments, S-peptide (residues 1–20
of RNase A) and S-protein (residues 21–124), that are
held together largely through hydrophobic interactions.
Although neither fragment alone has any ribonucleo-
lytic activity, RNase S has enzymatic activity similar to
that of RNase A. In general, nucleotide-binding proteins
have important biological function in a number of
cellular processes, as nucleotides are co-factors or sub-
strates for enzymes, regulators of protein function, or
act in concert with structural binding motifs.
From our studies, we show that the stability of
gas-phase noncovalent protein–ligand complexes may
not reflect their solution affinities for interactions with a
significant electrostatic component. Specifically, the
gas-phase intermolecular interactions of the S-peptide–
S-protein complex are significantly weaker than the
cytidine nucleotide–RNase S complex, even though the
interactions in solution are stronger for the S-peptide–
S-protein complex. We find that protein–nucleotide
binding can be nearly covalent, or “possesses a covalent-
like stability” in the gas phase [35].
Experimental
Positive ion electrospray ionization mass spectra were
acquired with a QqTOF mass spectrometer (Applied
Biosystems/SCIEX QSTAR Pulsar XL, Concord, ON,
Canada). A nanoESI source (Proxeon Biosystems,
Odense, Denmark) using borosilicate glass capillaries
with Au/Pd coatings (Proxeon) was operated at low
analyte flow conditions (50 nL/min). A metal sleeve
used to restrict pumping in the initial ca. 62-mm region
of the 20-cm long Q0-focusing quadrupole was used to
allow for improved trapping and transmission of the
noncovalent complexes [12, 13, 17].
For single MS measurements, the Q1 mass filter is
operated in the radiofrequency (rf)-only mode, while
the TOF analyzer is used to record mass spectra. For
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the selected precursor ion, and the precursor ion is then
accelerated before it enters the collision cell (Q2), where
it undergoes CAD with neutral argon molecules
(4 mTorr). The products are focused and transmitted to
the TOF analyzer. (An excellent account of the operat-
ing principles of the QqTOF is found in Chernushevich
et al. [36].) The declustering potential is increased to
induce ion fragmentation in the orifice-skimmer region
of the source area. The declustering potential is the
difference between the orifice voltage and the skimmer
voltage.
Bovine pancreatic RNase A, subtilisin-modified ribonu-
clease A (RNase S), cytidine 5=-triphosphate (CTP), cytidine
5=-diphosphate (CDP), cytidine 2=-monophosphate (2=-
CMP), and cytidine 3=-monophosphate (3=-CMP) were
purchased from Sigma-Aldrich (St. Louis, MO). All
protein samples were desalted with 10 mM ammonium
acetate before analysis using centrifugal filter devices
(10,000 molecular weight cutoff, Microcon and Amicon
Ultra; Millipore Corporation, Billerica, MA). The final
protein concentration for ESI-MS measurements was 5
M in 10 mM ammonium acetate, pH 6.6 unless noted
otherwise.
Matrix-assisted laser desorption/ionization (MALDI)-MS
experiments were performed with a Voyager DE-STR TOF
analyzer (Applied Biosystems, Foster City, CA). Sinapinic
acid (3,5-dimethoxy-4-hydroxycinnamic acid; -Aldrich)
was used as the matrix.
Results and Discussion
ESI-MS and MS/MS of Ribonuclease A Binding
to Cytidine Nucleotide Ligands
Consistent with previous ESI-MS studies for the com-
plexation of proteins to small nucleic acids [14, 19,
27–33], the noncovalent binding of RNase A to cytidine
nucleotides was readily observed. Zhang et al. previ-
ously measured using automated ESI-MS a solution
equilibrium dissociation constant (Kd) for the RNase A
association with 2=-CMP and CTP to be 1–2 M [19].
Figure 1 shows the ESI mass spectra of RNase A
(13,682 Da) complexed to 2=-CMP (323 Da), CDP (403
Da), and CTP (483 Da) in pH 6.6 solution. A protein–
ligand stoichiometry of 1:1 was observed for each of the
nucleotide ligands. The charge state of the most abun-
dant protein–ligand complex molecule was 8 for each
of the ligands studied. (The 8 charge state is the most
abundant species for RNase A alone at pH 6.6 (data not
shown).) However, the proportion of the formation of
the holocomplex increased with increasing number of
phosphate groups (for the same 1:10 protein–ligand
concentration ratio). The measured holo/apo ratio was
0.8, 2.9, and 11.6 for 2=-CMP, CDP, and CTP, respec-
tively. A small amount of the RNase A–ligand dimer
complex (less than 3% of the total protein signal) was
observed for CDP and CTP as well. Using a low
declustering potential of 60 V in the atmosphericpressure–vacuum interface, little dissociation of the
complexes were observed. A small amount of dissocia-
tion may have occurred for 2=-CMP binding to RNase
A, as an ion at m/z 324 for liberated 2=-CMP was
observed (Figure 1a).
Consistent with previous studies of the stability of
protein–DNA ionic complexes [37, 38], increasing salt
concentration reduces the relative abundance of the
RNase A–nucleotide complexes detected by ESI-MS.
Increasing the ammonium acetate concentration from
10 to 100 mM reduced the holo/apo ratio to 0.3, 0.9, and
2.3 for 2=-CMP, CDP, and CTP binding, respectively.
Similarly, increasing the ammonium acetate concentra-
tion further to 200 mM further reduced the holo/apo
ratio to 0.1, 0.1, and 0.3.
To investigate the stability of the protein–ligand
complexes, collisionally activated dissociation (CAD)
mass spectra were recorded for each of the multiply
charged complexes. Figure 2 shows the MS/MS spectra
of the 8 charged RNase A complex with 2=-CMP, CDP,
and CTP. Dissociation of the (M  8H  CMP)8
complex (where “M” is the RNase A protein) yields the
complementary (M  7H)7 and (CMP  H) product
ion pair. In addition, the (M  8H)8 apo-protein with
concurrent loss of neutral 2=-CMP was observed as well
(Figure 2a). MS/MS of the complex with 3=-CMP shows
similar behavior (data not shown). For most weakly-
Figure 1. Positive ion ESI mass spectra of RNase A with (a)
2=-CMP, (b) CDP, (c) CTP at a 1:10 protein-ligand concentration
ratio in 10 mM ammonium acetate, pH 6.6. A declustering
potential of 60 V in the atmospheric pressure–vacuum interface
was used. Peaks representing the nucleotide-bound holoform of
the protein are labeled with the filled circles, and the peaks for the
apo-protein are labeled with open circles. [Free, unbound 2=-CMP
was detected at m/z 324 in (a)].bound noncovalent protein complex, regardless of their
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ciation of the protein-binding partner from the complex.
The CAD behavior of RNase A binding to CDP and
CTP, however, is substantially different than for 2=-
CMP binding. Dissociation of the (M  8H  CDP)8
complex yields the complementary (M  7H)7 (m/z
1955) and (CDPH) (m/z 404) product ion pair as one
dissociation pathway, and a minor pathway yielding
the (M 8H)8 protein with loss of neutral CDP (Figure
2b). (The y8 product ion from dissociation of the N-
terminal bond to Pro-117 is readily observed in CAD
mass spectra of RNase A [39].) However, the predom-
inant route is interpreted as the dissociation of a cova-
lent phosphate bond within the diphosphate group of
CDP and the subsequent release of charged CMP.
Assuming that the phosphate group is the primary
contact site for attachment to RNase A, as it is in X-ray
crystallographic data for oligonucleotide binding to the
enzyme [26, 40], the terminal phosphate group remains
bound to the protein and the leaving group is a mole-
cule of CMP. An ion at m/z 324 is the (CMP  H), and
its complement is the (M  7H  phosphate)7 (m/z
1967). Loss of neutral CMP and formation of the (M 
8H  phosphate)8 (m/z 1721) is observed as well.
Dissociation of the (M  8H  CTP)8 complex
yields predominantly products from the cleavage of the
terminal phosphate group(s) of CTP, i.e., loss of intact
CTP is not observed. Both (CMP  H) and (CDP 
Figure 2. CAD mass spectra of the 8 charged complex between
RNase A and (a) 2=-CMP (40 V collision energy, CE), (b) CDP (CE
 50 V), and (c) CTP (CE  50 V) in 10 mM ammonium acetate,
pH 6.6. The 8 charged precursor ions are labeled with filled
circles. Product ions for the apo-protein are labeled with open
circles. Retention of one phosphate group by the product ion is
represented by “P”, and retention of two phosphates is labeled
with “PP.”H) leaving groups were observed at m/z 324 and 404,respectively. One and two phosphate binding to RNase
A (for both 7 and 8 charged products) was mea-
sured (Figure 2c and Scheme 1). Loss of H2O from the
7 and 8 charged products is observed also. Increas-
ing the collision energy results in the increase in relative
abundance of the protein bound to one phosphate
group and the protonated CDP molecule (Figure 3).
Conceivably this increase of the abundance of the one
phosphate-bound protein could result from secondary
dissociation of the two phosphate-bound protein with
increasing collision energies.
The interaction between the cytidine nucleotides
with RNase A is largely through ionic, noncovalent
forces [33, 41]. ESI mass spectra of RNase A with CDP
and CTP in acidic pH (less than 4) and with 50%
(vol/vol) methanol or acetonitrile shows the apo-protein
and the free nucleotide ligand as the major components.
Likewise, MALDI-TOF mass spectra of RNase A incu-
bated with CTP in 10 mM ammonium acetate, pH 6.6 for
over 1 h and spotted onto a MALDI plate with sinapinic
acid matrix and 0.1% trifluoroacetic acid shows only the
apo-protein, i.e., transfer of a phosphate group to
RNase A does not result in a covalent product from a
solution reaction. In vacuo, the electrostatic interaction
of the positively charged, desolvated protein and the
negatively charged ligand is greatly strengthened com-
pared with its properties in solution. The strength of
charge–charge interactions is approximately inversely
proportional to the dielectric constant of the medium.
Removal of solvent (i.e., water) replaces the dielectric
term to that of either vacuum (dielectric constant of one)
or of the protein itself (estimated to be 3–4), resulting
in an increase in the electrostatic forces.
The increased avidity of noncovalent complexes
Scheme 1. Products from the CAD of RNase A (M) bound to
CMP, CDP, and CTP. The structure of CTP and the P–O bonds
cleaved upon CAD are shown (top).driven by charge–charge interactions has been ob-
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results in a near-covalent strength interaction between
the phosphate groups of CDP and CTP to RNase A. It is
not clear why CAD of the protein bound to the mono-
phosphate nucleotide CMP does not result in transfer of
a phosphate group to RNase A. Zhang et al. measured
the solution binding constants for RNase A and 2=-CMP
and CTP to be 2.0 and 0.7 M, respectively [19].
Whether the 2- to 3-fold higher binding affinity for
CTP-binding than for 2=-CMP-binding can be rational-
ized by the additional diphosphate and/or the different
attachment position of the phosphate group to ribose
(5= versus 2=) is unclear.
We performed separate CAD experiments for CMP,
CDP, and CTP to investigate the relative stabilities of
their P–O bonds. Cleavage of a P–O bond resulting in
the loss of one and two phosphate groups is readily
observed for CTP, and the loss of one phosphate group
is observed for CDP. MS/MS of CMP results primarily
in loss of the cytidine base. Thus, the general intrinsic
stabilities of the P–O bonds for the cytidylic acid ligands
appear to be carried forward into the RNase A–cytidylic
acid complexes.
ESI-MS and MS/MS of Ribonuclease
S–Nucleotide Complexes
RNase A treated with subtilisin yields a modified
Figure 3. MS/MS spectra of the (M  8H  CTP)8 complex (M
 RNase A) at (a) 45 V, (b) 50 V, and (c) 55 V collision energies.
The 8 charged precursor ions are labeled with filled circles.
Product ions for the apo-protein are labeled with open circles.
Retention of one phosphate group by the product ion is repre-
sented by “P”, and retention of two phosphates is labeled with
“PP.” Peaks for the loss of water are labeled with an asterisk
symbol.RNase A, RNase S. RNase S has nearly the sameenzymatic activity as RNase A. Subtilisin cleaves RNase
A between Ala-20 and Ser-21 to generate the S-peptide
(residues 1–20, 2166 Da) and the S-protein (residues
21–124, 11,534 Da). The S-peptide is necessary for
maintaining enzymatic activity, as His-12 has a funda-
mental role in its catalytic activity [3, 23, 26]. S-peptide
and S-protein interact mostly through hydrophobic
interactions with a solution equilibrium dissociation
constant of 1 nM to form active RNase S [26].
The direct detection of the noncovalent RNase S
complex by ESI-MS has been reported by us some 15
years prior [3, 23], but to our knowledge it has not been
reported by any laboratory since. Although the solution
binding constant may suggest a stable complex, the
gas-phase S-peptide/S-protein complex is extremely
fragile, primarily because of the hydrophobic forces
that maintain the complex. Removal of water should
diminish greatly the avidity of the complex in the gas
phase. However, similar to the prototype, in-house built
single quadrupole mass spectrometer used to measure
the RNase S complex originally [3, 23], the commercial
QqTOF instrument used for the present study was
modified to increase the local pressure in the initial ion
transfer stage. Improvements in sensitivity for large
noncovalently-bound protein complexes appear to de-
rive from improved cooling and focusing in Q0 pro-
duced by raising the pressure in this region [12, 13]. A
metal sleeve (now called IonCooler for the Applied
Biosystems QSTAR instruments) that is fitted around
the initial ion entrance region of Q0 increases the local
pressure to greater than 30 mTorr and greatly improves
detection of weakly-bound complexes. This is demon-
strated in Figure 4a, showing primarily the detection of
intact RNase S complex with 7 and 8 charges.
Without the metal sleeve to increase the pressure in the
Q0 region, ions for the intact RNase S measured to less
than 30% relative abundance of the dissociated S-protein
and S-peptide (data not shown). CAD of the 8 charged
complex results in its dissociation into the expected S-
protein (6 charged) and S-peptide (2 charged) comple-
mentary products, exclusively (Figure 4b).
As RNase S has similar enzymatic activity to RNase
A in solution, it would be expected that RNase S should
interact similarly to cytidine nucleotides. Using a con-
centration ratio of 1:10 protein:nucleotide in solution,
the cytidine nucleotides was observed to form a 1:1
complex with intact RNase S. However, as observed for
RNase A (Figure 1), CDP- and CTP-binding promote
the formation of the 1:1 complex more readily than
2=-CMP-binding (data not shown). The measured holo-
apo ratio was 1.3, 3.8, and 4.7 for 2=-CMP, CDP, and
CTP, respectively. The full S-peptide–S-protein complex
is required for enzymatic activity, and also for cytidine
nucleotide binding. HPLC-separated and purified S-
peptide and S-protein were reconstituted separately
with tenfold excess of CTP (pH 6.6) and measured by
ESI-MS. No detectable CTP-binding was observed for
the S-peptide. A holo-apo ratio of only 0.1 was mea-
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than for the full RNase S complex.
CAD of the RNase S–nucleotide complexes high-
lights the significant differences between gas-phase
hydrophobic and electrostatic interactions and the dif-
ferences observed in solution-phase and gas-phase
binding. For the RNase S-nucleotide gas-phase com-
plexes, the reduction of hydrophobic forces and the
increasing strength of the electrostatic forces contribute
to their behavior upon CAD. In solution, the equilibrium
binding constant for the S-protein–S-peptide complex-
ation fall in the nanomolar range, whereas cytidine–
nucleotide binding to RNase S is expected to be in the
micromolar concentration range. CAD of the gas-phase
8 charged RNase S-nucleotide complex yields prod-
ucts that are contrary to that expected from solution;
S-protein and S-peptide dissociate as separated prod-
Figure 4. (a) ESI mass spectra of RNase S (R
declustering potential of 0 V in the atmos
commercial sample of RNase S is a mixture of tw
1–20 (2095 and 2166 Da, respectively), and two S-
21–124 and 22–124 (11,534 and 11,447 Da), consis
an expanded view of the RNase S complex pe
cloverleaf, (1–20)/(21–124) complex; filled spad
124) complex; [open square], S-protein 21–124; [
the 8 charged RNase S complex (m/z 1713.5; CE
S-protein (residues 21–124) product pair.ucts, and the nucleotide remains bound to the S-protein(Figure 5). The active site of RNase A binding to nucleo-
tides involves the side chains of His-12, His-119, Lys-41,
and Gln-11 [26, 40, 48]. The electrostatic interactions be-
tween the phosphate groups of CMP, CDP, and CTP, and
the S-protein appear to be retained in the CAD experi-
ment. Fragmentation of the 6 charged S-protein–nucle-
otide complex in a “pseudo-MS3” experiment, in which
the declustering potential in the atmospheric pressure–
vacuum interface is elevated to 60–70 V to induce
dissociation of the S-peptide from the RNase S-nucleotide
complex [39, 49], and selection of the targeted S-protein–
nucleotide precursor ion for further CAD results in the
separation of CMP as the leaving group and one and two
phosphate groups being retained on the S-protein for the
S-protein–CDP and S-protein–CTP complexes, respec-
tively. Pseudo-MS3 of the S-protein/2=-CMP generates
only the separated S-protein and 2=-CMP product ion pair
M in 10 mM ammonium acetate, pH 6.6). A
ic pressure–vacuum interface was used. The
peptide (S-Pep) components, residues 1–19 and
in (S-Prot) polypeptides encompassing residues
ith our previous reports [3, 23]. The inset shows
illed diamond, (1–19)/(21–124) complex; filled
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 10(Figure 6). Thus, nucleotide binding to S-protein behaves
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interactions predominate.
Unusual Stability of Gas Phase
Charge–Charge Interactions
The dissociation of covalent bonds over noncovalent
bonds in the CAD of noncovalent complexes, as dem-
onstrated by the RNase A/S-nucleotides examples, has
been reported previously for other systems. An early
example was presented by Feng on the unusual gas-
phase stability of a peptide–polyamine complex [50].
The polyamine spermine and a 14-residue spermine-
binding peptide (SBP) with 4 glutamic residues and no
basic residues form a complex, as measured by ESI-MS.
Its binding constant in solution is 0.1 mM, but the 1:1
complex was readily detected. However, dissociation of
the complex by CAD was not found; at high collision
energy cleavage of a covalent peptide bondwas observed.
It was hypothesized that its “stability in the gas phasemay
be due to increased Coulombic stabilization energy of the
opposite charges in the solvent-free environment.”
The near covalent stability of gas-phase noncovalent
electrostatic interactions has been featured in reports by
Woods’ laboratory [44]. In one publication, they report
on the ESI-MS/MS of the 1:1 complex formed between
a highly basic peptide, VLRRRRKRVN, and phospho-
rylated SVSTDpTpSAE. Two dissociation pathways
were observed for the complex: disruption of the elec-
trostatic interactions between the Arg residues and the
Figure 5. CAD mass spectra of the 8 charged 1:1 complex
between RNase S (residues 1–19 S-peptide and residues 21–124
S-protein) and (a) 2=-CMP, (b) CDP, and (c) CTP (11 V collision
energy, CE). (The low abundance peak at m/z 1083 is the S-peptide
1–20 resulting from low resolution precursor ion selection.)phosphate groups, and separation of the peptides withconcurrent dissociation of the C–O side-chain covalent
bond and transfer of HPO3 from either pT or pSi to the
basic peptide. Terrier et al. recently reported a study of
noncovalent complexes involving single-stranded DNA
and polybasic compounds, including poly-lysine and
penta-arginine [51]. For some of the complexes, MS/MS
of the DNA-polybasic complex yielded fragmentation
of DNA covalent bonds and an oligonucleotide frag-
ment remain bound to the polybasic compound. This
phenomenon is similar to an earlier report by Griffey
and coworkers, in which CAD of oligoribonucleotide–
ligand complexes generated product ions representing
RNA fragments bound to the ligand [52].
Numerous studies have suggested an apparent link
between the energy required for dissociation of gas-
phase noncovalent complexes and the solution phase
binding constants or activation energies [21, 23, 46].
Despite such studies, a number of others have reported
on the enhanced gas-phase stability of mono- and
oligonucleotides complexed with proteins compared to
their solution phase characteristics [28, 31, 32]. Benke-
stock et al. noted that upon CAD of a RNase A-dC6
complex, dissociation of covalent bonds within dC8
Figure 6. Pseudo-MS3 of the 6 charged S-protein (residues
21–124) complex with (a) 2=-CMP, (b) CTP, and (c) CTP. A
declustering potential of60–70 V was used to induce dissociation
of the RNase S/nucleotide complex. The 6 charged precursor
ions for the S-protein/2=-CMP (m/z 1976), S-protein/CDP (m/z
1990), and S-protein/CTP (m/z 2003, 6) were selected for further
MS/MS (55 V collision energy, CE). The 6 charged precursors
are labeled with filled squares. Product ions are labeled with open
squares. Retention of one phosphate group by the product ion is
represented by “P”, and retention of two phosphates is labeled
with “PP.” Peaks for the loss of water are labeled with an asterisk
symbol. [The number symbol-labeled peak at m/z 1927 is assigned
as the singly-sodiated version of (S-protein)6 appearing at m/z
1923.]occurred, with loss of dC6 from the gas-phase complex
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noncovalent RNase A–CMP complex (without breaking
covalent bonds), as we observed in the present study.
Huang et al. studied the effect of the declustering
energy in the atmospheric pressure–vacuum interface
of their triple quadrupole instrument on the stability of
the noncovalent protein–ligand ras–GDP complex [28].
It was found that a substantial amount of energy was
required to dissociate the gas-phase ras–GDP complex.
In fact, the resulting mass spectrum shows peaks that
could be assigned as the transfer of phosphate to the ras
protein at high CAD energy; however, the authors
could not assign these peaks in the original report.
Our laboratory recently reported the complexation of
polyamine spermine and spermidine with an acidic
protein implicated in Parkinson’s disease, -synuclein
[53]. The solution Kd for the 1:1 protein:spermine com-
plex of 1 mM was confirmed by ligand titration and
ESI-MS. The charge–charge interaction between polybasic
spermine and spermidine and the acidic C-terminal tail of
the protein likely contributed to the enhanced gas-
phase stability of the complex that allowed ESI-MS
detection for a weak solution phase complex. Unlike the
behavior observed for RNase A/S binding to CDP and
CTP, CAD of the protein–spermine complex yielded
only dissociation of the noncovalent bonds, separating
the spermine ligand from the 140-residue, 14.5 kDa
-synuclein protein. However, we showed also that
electron capture dissociation (ECD) favors cleavage of
covalent backbone bonds of protein molecules primar-
ily [53]. This characteristic of ECD translates directly to
noncovalent protein–ligand complexes, as covalent
backbone bonds of protein complexes are dissociated,
but the noncovalent ligand interaction is retained. For
the -synuclein–spermine complex, ECD generates
c-/z· product ions that retain the protein–spermine
noncovalent interaction. Spermine binding was local-
ized to residues 106–138. Thus, the enhancement of the
gas-phase stabilities of noncovalent complexes by elec-
trostatic interactions can be useful to detect weak solu-
tion phase complexes by ESI-MS.
The results of this study highlight several important
points for measuring noncovalent protein–ligand com-
plexes and, perhaps, noncovalent complexes in general
by ESI-MS. The ability of ESI-MS to detect a specific
noncovalent complex depends on factors related to both
its solution-phase and gas-phase properties. Schug and
Linder define a relationship, termed relative transmis-
sion factor, as “the relationship between measured ion
intensities and the initial concentration of each compo-
nent” [54, 55]. The relative transmission factor will
depend on the binding affinities the molecular partners
have for each other in solution, and this in turn is
influenced by the structures of the components and the
types and strengths of the forces holding them together
in solution. Once these specific interactions are formed
in solution, the process of transferring them to the gas
phase will then dictate whether they will be observed
by ESI-MS. Unlike in solution, processes in the gasphase are not at true equilibrium, as noncovalent bonds
disrupted in the gas phase generally remain disrupted
throughout the ESI-MS process. This has implications
for applying ESI-MS to measure absolute ligand bind-
ing affinities and to screen compounds for binding to
drug targets in the pharmaceutical and biotechnology
sectors. If the gas-phase binding affinities are not suffi-
ciently low to preclude their detection or significantly
reduce their apparent abundances as measured by MS,
then ESI-MS could be used to assess relative or absolute
binding affinities for a range of compounds. However,
it would be difficult to envision that ESI-MS could be
considered as a general tool to measure protein–ligand
complexes because of the apparent differences in solution-
phase and gas-phase binding affinities, as found for the
RNase S-nucleotide example presented in the current
study. An ideal situation for comparing binding affinities
for a variety of compounds would be cases in which the
dominant type of interaction in the gas phase is similar.
Conclusions
The magnitudes of noncovalent protein binding in
aqueous solution can be determined largely by hydro-
phobic effects. However, the stability of gas-phase
noncovalent complexes depends on the binding mode
employed in holding complexes together. In the gas
phase, electrostatic interactions are strengthened and
may be difficult to disrupt. For RNase A/S binding to
nucleotides, although CMP and CTP have similar solu-
tion binding affinities, RNase A/S-CTP is significantly
more stable in the gas phase, as probed by ESI-MS and
MS/MS experiments. ESI-MS/MS of RNase A-CMP
results in facile loss of CMP, whereas CAD of RNase
A-CTP leads to dissociation of covalent amide bonds of
the RNase A backbone and fragmentation of the cytidine–
nucleotide structure. The diphosphate group from CTP
remains bound to the protein because of strengthened
electrostatic interactions in the gas phase. CAD-MS/MS of
RNase S-CDP/CTP dissociates S-peptide from the re-
maining S-protein–nucleotide complex, despite the
three orders of magnitude difference in solution bind-
ing favoring S-peptide–S-protein association. Thus,
CAD-MS/MS may not be a generally applicable
method for gauging or predicting solution binding
constants, especially for complexes held together by
different types of noncovalent forces.
Thus, we find that protein–nucleotide binding can be
nearly covalent or irreversible in the gas phase. This
suggests a possible new strategy to functionally probe for
and identify new protein kinases, enzymes that modify
other proteins by phosphorylation. Protein kinases repre-
sent perhaps the single largest mammalian enzyme family
withmore than 500members in the human proteome. The
ATP-binding sites of protein kinases are highly conserved.
Protein binding to ATP (adenosine 5=-triphosphate) has
been measured directly using ESI-MS by several labora-
tories [14, 27, 29, 30]. Preliminary ESI-MS experiments by
our laboratory suggest that the kinase–ATP noncovalent
1207J Am Soc Mass Spectrom 2008, 19, 1199–1208 ESI-MS OF PROTEIN–LIGAND COMPLEXESinteraction is exceedingly stable in the gas phase, and it
may be possible to design strategies to identify the ATP-
binding sites of protein kinases using mass spectrometry
exclusively.
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